Abstract
The link between hypertriglyceridaemia (HTG) and/or hypercholesterolaemia (HCL) and neuropathy is uncertain. We retrospectively reviewed records of 100 consecutive patients investigated for acquired chronic axonal distal polyneuropathy of unknown cause. Findings were compared with those of 102 consecutive controls. Patients with idiopathic neuropathy were subsequently compared with age- and gender-matched controls. There were more neuropathy patients than controls with HCL, defined as cholesterol levels >5 mmol/L (63 vs. 45.1%; p = 0.011). Neuropathy patients also had higher cholesterol levels than controls (p = 0.04). Cholesterol-lowering drug usage was similar in both groups. HTG (defined as >2 mmol/L) and triglyceride levels were comparable in both groups. HTG ranged from 2.1–4.2 mmol/L in neuropathy patients. A cause for neuropathy was identified in 59 patients. Thirty-one had impaired glucose metabolism. Forty-one had idiopathic neuropathy. No link was demonstrated between idiopathic neuropathy or painful idiopathic neuropathy, and HTG/HCL. Mean triglyceride and cholesterol levels in patients with idiopathic neuropathy were comparable to those of controls. HTG was significantly more common (p = 0.027), and triglyceride levels significantly higher (p = 0.005) in patients with neuropathy due to diabetes/impaired glucose tolerance (IGT)/alcoholism, than in patients with neuropathy of any other cause. These results suggest HCL >5 mmol/L may represent a cofactor contributing to presence of neuropathy irrespective of the underlying cause. They on the other hand do not support mild/moderate HTG as an independent cause of neuropathy. HTG is common in patients with neuropathy associated with diabetes/IGT/chronic alcoholism, where it may play a role in peripheral nerve damage. As previously reported, IGT was in our cohort frequent, present in one case in three, in the absence of another identifiable aetiology.
Similar content being viewed by others
References
Hughes RA, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS et al (2004) A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 127:1723–1730
McManis PG, Windebank AJ, Kiziltan M (1994) Neuropathy associated with hyperlipidemia. Neurology 44:2185–2186
Drory VE, Groozman GB, Rubinstein A, Korczyn AD (1999) Hypertriglyceridemia may cause a subclinical peripheral neuropathy. Electromyogr Clin Neurophysiol 39:39–41
Kassem HS, Azar ST, Zantout MS, Sawaya RA (2005) Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients. Neuro Endocrinol Lett 26:775–779
David WS, Mahdavi Z, Nance M, Khan M (1999) Hyperlipidemia and neuropathy. Electromyogr Clin Neurophysiol 39:227–230
Teunissen LL, Franssen H, Wokke JH, van der Graaf Y, Linssen WH, Banga JD et al (2002) Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J Neurol Neurosurg Psychiatry 72:5950–5955
Herrmann DN, Ferguson ML, Pannoni V, Barbano RL, Stanton M, Logigian EL (2004) Plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies. Neurology 63:879–885
Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G et al (2008) The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912–1925
Smith AG, Rose K, Singleton JR (2008) Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci 273:25–28
Visser NA, Notermans NC, van der Schouw YT, Wokke JHJ, van den Bergh LH, Vrancken AJE (2010) Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. J Peripher Nerv Syst [Abstract] 15(3):285–286
Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new world-wide definition. Lancet 366:1059–1062
Dyck PJ, Oviatt KF, Lambert EH (1981) Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 10:222–226
McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC (1984) Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 47:530–535
Verghese J, Bieri PL, Gellido C, Schaumburg HH, Herskovitz S (2001) Peripheral neuropathy in young-old and old-old patients. Muscle Nerve 24:1476–1481
Rajabally YA (2011) Neuropathy and impaired glucose tolerance: an updated review of the evidence. Acta Neurol Scand (Epub ahead of print)
Singleton JR, Smith AG, Bromberg MB (2001) Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225–1228
Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24:1448–1453
Novella SP, Inzucchi SE, Goldstein JM (2001) The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24:1229–1231
Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP (2006) Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 63:1075–1079
Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C et al (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350
Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, Sindrup SH (2002) Statins and risk of polyneuropathy: a case-control study. Neurology 58:1333–1337
Acknowledgments
We thank Dr R.J. Abbott, Dr L. Damian, Dr. M.S. Damian, Dr. P.C. Critchley and Dr. M.C. Lawden, Department of Neurology, University Hospitals of Leicester, Leicester, U.K., for referring their patients.
Conflicts of interest
None Declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rajabally, Y.A., Shah, R.S. Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol 258, 1431–1436 (2011). https://doi.org/10.1007/s00415-011-5950-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-5950-z